Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Re. Award - PA: Sex, Gender and Intersectionality in Health Research

University of Calgary

$105,000.00

Determining the Effect of Estrogen-Mediated Sex-Differences in Adipose Progenitor Cell Dynamics on the Development of Obesity.

EF 2023-24

Résumé
Current understanding of the pathophysiological events linking obesity to cardiovascular disease (CVD) is predicated on a body of data generated predominately in male animals. The default use of male animals has led to a paucity of knowledge in sex-specific mechanisms and the development of "one-size-fits-all" treatments that fail to account for the influence of sex hormones. CVD risk in obesity is not driven by the absolute amount of body fat, but rather by its distribution and function. Males tend to accumulate fat around internal (visceral) organs, which increases the risk for CVD. In contrast, expansion of fat located beneath the skin (subcutaneous) is characteristic of females and associated with a favourable metabolic profile. After menopause, a shift towards the male-like pattern of body fat distribution coincides with an increase in the risk for CVD. Our preliminary data suggest that estrogen- mediated responses of fat-residing stem cells underlie sex differences in fat distribution and CVD risk. Thus, we will determine how sex and estrogen influence site-specific stem cell responses and metabolic health. We will use a mouse model of diet-induced obesity. The role of estrogen in young female mice will be determined by removing the ovaries, with a subset of ovariectomized females supplemented with estrogen. The response of stem cells to obesogenic conditions will be measured using a state-of-the-art transgenic model that permits the identification of new fat cells in the whole animal. Finally, after prolonged obesity, indices reflecting the function and health of fat tissue will be measured. These studies will provide new insight that may help to explain why risk for CVD differs between the sexes and to identify a role of estrogen in these processes.
Programme
Doctoral Re. Award - PA: Sex, Gender and Intersectionality in Health Research
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
498433
Name
Scheidl Taylor B
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Determining the Effect of Estrogen-Mediated Sex-Differences in Adipose Progenitor Cell Dynamics on the Development of Obesity.
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Re. Award - PA: Sex, Gender and Intersectionality in Health Research
Keyworddelim
Adipogenesis; Estrogen; Flow Cytometry; Obesity; Progenitor Cells; Sex-Differences
Abstract
Current understanding of the pathophysiological events linking obesity to cardiovascular disease (CVD) is predicated on a body of data generated predominately in male animals. The default use of male animals has led to a paucity of knowledge in sex-specific mechanisms and the development of "one-size-fits-all" treatments that fail to account for the influence of sex hormones. CVD risk in obesity is not driven by the absolute amount of body fat, but rather by its distribution and function. Males tend to accumulate fat around internal (visceral) organs, which increases the risk for CVD. In contrast, expansion of fat located beneath the skin (subcutaneous) is characteristic of females and associated with a favourable metabolic profile. After menopause, a shift towards the male-like pattern of body fat distribution coincides with an increase in the risk for CVD. Our preliminary data suggest that estrogen- mediated responses of fat-residing stem cells underlie sex differences in fat distribution and CVD risk. Thus, we will determine how sex and estrogen influence site-specific stem cell responses and metabolic health. We will use a mouse model of diet-induced obesity. The role of estrogen in young female mice will be determined by removing the ovaries, with a subset of ovariectomized females supplemented with estrogen. The response of stem cells to obesogenic conditions will be measured using a state-of-the-art transgenic model that permits the identification of new fat cells in the whole animal. Finally, after prolonged obesity, indices reflecting the function and health of fat tissue will be measured. These studies will provide new insight that may help to explain why risk for CVD differs between the sexes and to identify a role of estrogen in these processes.
Competitiondate
202310
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Scheidl, Taylor B
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~